{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T22:58:51Z","timestamp":1773269931408,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T00:00:00Z","timestamp":1598832000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T00:00:00Z","timestamp":1598832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Existing imaging techniques have a low ability to detect lymph node metastasis (LNM) of gallbladder cancer (GBC). Gallbladder removal by laparoscopic cholecystectomy can provide pathological information regarding the tumor itself for incidental gallbladder cancer (IGBC). The purpose of this study was to identify the risk factors associated with LNM of IGBC and to establish a nomogram to improve the ability to predict the risk of LNM for IGBC.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>A total of 796 patients diagnosed with stage T1\/2 GBC between 2004 and 2015 who underwent surgery and lymph node evaluation were enrolled in this study. We randomly divided the dataset into a training set (70%) and a validation set (30%). A logistic regression model was used to construct the nomogram in the training set and then was verified in the validation set. Nomogram performance was quantified with respect to discrimination and calibration.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The rates of LNM in T1a, T1b and T2 patients were 7, 11.1 and 44.3%, respectively. Tumor diameter, T stage, and tumor differentiation were independent factors affecting LNM. The C-index and AUC of the training set were 0.718 (95% CI, 0.676\u20130.760) and 0.702 (95% CI, 0.659\u20130.702), respectively, demonstrating good prediction performance. The calibration curves showed perfect agreement between the nomogram predictions and actual observations. Decision curve analysis showed that the LNM nomogram was clinically useful when the risk was decided at a possibility threshold of 2\u201363%. The C-index and AUC of the validation set were 0.73 (95% CI: 0.665\u20130.795) and 0.692 (95% CI: 0.625\u20130.759), respectively.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>The nomogram established in this study has good prediction ability. For patients with IGBC requiring re-resection, the model can effectively predict the risk of LNM and make up for the inaccuracy of imaging.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12885-020-07341-y","type":"journal-article","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T12:03:04Z","timestamp":1598875384000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["A predictive nomogram for lymph node metastasis of incidental gallbladder cancer: a SEER population-based study"],"prefix":"10.1186","volume":"20","author":[{"given":"Yingnan","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuolong","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huajie","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingren","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chentao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7718-2805","authenticated-orcid":false,"given":"Jinfu","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,31]]},"reference":[{"issue":"5","key":"7341_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359\u201386.","journal-title":"Int J Cancer"},{"issue":"2","key":"7341_CR2","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.suc.2018.12.008","volume":"99","author":"L Hickman","year":"2019","unstructured":"Hickman L, Contreras C. Gallbladder cancer: diagnosis, surgical management, and adjuvant therapies. Surg Clin North Am. 2019;99(2):337\u201355.","journal-title":"Surg Clin North Am"},{"issue":"1","key":"7341_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/cam4.2679","volume":"9","author":"W Mao","year":"2020","unstructured":"Mao W, Deng F, Wang D, et al. Treatment of advanced gallbladder cancer: a SEER-based study. Cancer Med. 2020;9(1):141\u201350.","journal-title":"Cancer Med"},{"issue":"2","key":"7341_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1001\/jamasurg.2016.3642","volume":"152","author":"CG Ethun","year":"2017","unstructured":"Ethun CG, Postlewait LM, Le N, et al. Association of Optimal Time Interval to re-resection for incidental gallbladder Cancer with overall survival: a multi-institution analysis from the US Extrahepatic biliary malignancy consortium. JAMA Surgery. 2017;152(2):143\u20139.","journal-title":"JAMA Surgery"},{"key":"7341_CR5","first-page":"iv1","volume":"30 Suppl 4","author":"S Galodha","year":"2019","unstructured":"Galodha S, Saxena R, Singh R, et al. Incidental gallbladder cancer: can we improve survival? Ann Oncol. 2019;30 Suppl 4:iv1.","journal-title":"Ann Oncol"},{"issue":"6","key":"7341_CR6","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1097\/SLA.0b013e31806beec2","volume":"245","author":"SP Shih","year":"2007","unstructured":"Shih SP, Schulick RD, Cameron JL, et al. Gallbladder cancer: the role of laparoscopy and radical resection. Ann Surg. 2007;245(6):893\u2013901.","journal-title":"Ann Surg"},{"key":"7341_CR7","doi-asserted-by":"crossref","unstructured":"Steffen T, Ebinger SM, Tarantino I et al. Prognostic Impact of Lymph Node Excision in T1 and T2 Gallbladder Cancer: a Population-Based and Propensity Score-Matched SEER Analysis. J Gastrointest Surg. 2020;24(3):633\u201342.","DOI":"10.1007\/s11605-019-04175-3"},{"issue":"26","key":"7341_CR8","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.3748\/wjg.v24.i26.2886","volume":"24","author":"DX Fan","year":"2018","unstructured":"Fan DX, Xu RW, Li YC, et al. Impact of the number of examined lymph nodes on outcomes in patients with lymph node-negative gallbladder carcinoma. World J Gastroenterol. 2018;24(26):2886\u201392.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"7341_CR9","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1097\/SLA.0b013e31822238d8","volume":"254","author":"H Ito","year":"2011","unstructured":"Ito H, Ito K, D'Angelica M, et al. Accurate staging for gallbladder cancer: implications for surgical therapy and pathological assessment. Ann Surg Oncol. 2011;254(2):320\u20135.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"7341_CR10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ejso.2015.10.013","volume":"42","author":"SH Kim","year":"2016","unstructured":"Kim SH, Chong JU, Lim JH, et al. Optimal assessment of lymph node status in gallbladder cancer. Eur J Surg Oncol. 2016;42(2):205\u201310.","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"7341_CR11","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1007\/s00464-011-2044-z","volume":"26","author":"V Paolucci","year":"2012","unstructured":"Goetze TO, Paolucci V. The prognostic impact of positive lymph nodes in stages T1 to T3 incidental gallbladder carcinoma: results of the German registry. Surg Endosc. 2012;26(5):1382\u20139.","journal-title":"Surg Endosc"},{"issue":"23","key":"7341_CR12","doi-asserted-by":"publisher","first-page":"738","DOI":"10.21037\/atm.2019.11.112","volume":"7","author":"Z Xiao","year":"2019","unstructured":"Xiao Z, Shi Z, Hu L, et al. A new nomogram from the SEER database for predicting the prognosis of gallbladder cancer patients after surgery. Ann Transl Med. 2019;7(23):738.","journal-title":"Ann Transl Med"},{"key":"7341_CR13","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ejrad.2018.11.034","volume":"110","author":"LE de Savornin","year":"2019","unstructured":"de Savornin LE, de Bitter T, van Laarhoven C, et al. The diagnostic accuracy of CT and MRI for the detection of lymph node metastases in gallbladder cancer: a systematic review and meta-analysis. Eur J Radiol. 2019;110:156\u201362.","journal-title":"Eur J Radiol"},{"issue":"31","key":"7341_CR14","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.2217\/fon-2019-0377","volume":"15","author":"J Mu","year":"2019","unstructured":"Mu J, Jia Z, Yao W, et al. Predicting lymph node metastasis in early gastric cancer patients: development and validation of a model. Future Oncol (London, England). 2019;15(31):3609\u201317.","journal-title":"Future Oncol (London, England)"},{"key":"7341_CR15","doi-asserted-by":"publisher","unstructured":"Dan W, Chongshun L, Tingyu Y, et al. A Nomogram for predicting lymph nodal metastases in patients with Appendiceal cancers: an analysis of SEER database. J Investig Surg. 2020. https:\/\/doi.org\/10.1080\/08941939.2019.171146.","DOI":"10.1080\/08941939.2019.171146"},{"issue":"6","key":"7341_CR16","first-page":"288","volume":"20","author":"DY Hu","year":"2019","unstructured":"Hu DY, Cao B, Li SH, et al. Incidence, risk factors, and a predictive model for lymph node metastasis of submucosal (T1) colon cancer: a population-based study. J Investig Surg. 2019;20(6):288\u201393.","journal-title":"J Investig Surg"},{"key":"7341_CR17","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3389\/fonc.2019.00409","volume":"9","author":"Z Wang","year":"2019","unstructured":"Wang Z, Li Y, Jiang W, et al. Simple cholecystectomy is adequate for patients with T1b gallbladder adenocarcinoma < 1 cm in diameter. Front Oncol. 2019;9:409.","journal-title":"Front Oncol"},{"issue":"5","key":"7341_CR18","doi-asserted-by":"publisher","first-page":"563","DOI":"10.6004\/jnccn.2017.0059","volume":"15","author":"AB Benson","year":"2017","unstructured":"Benson AB, D'Angelica MI, Abbott DE, et al. NCCN guidelines insights: Hepatobiliary cancers, version 1.2017. J Natl Compr Cancer Netw. 2017;15(5):563\u201373.","journal-title":"J Natl Compr Cancer Netw"},{"key":"7341_CR19","doi-asserted-by":"publisher","first-page":"v28","DOI":"10.1093\/annonc\/mdw324","volume":"27","author":"JW Valle","year":"2016","unstructured":"Valle JW, Borbath I, Khan SA, et al. Biliary cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27:v28\u201337.","journal-title":"Ann Oncol"},{"issue":"5","key":"7341_CR20","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1080\/00365521.2017.1284895","volume":"52","author":"M Sternby Eilard","year":"2017","unstructured":"Sternby Eilard M, Lundgren L, Cahlin C, et al. Surgical treatment for gallbladder cancer - a systematic literature review. Scand J Gastroenterol. 2017;52(5):505\u201314.","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"7341_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12957-018-1556-6","volume":"17","author":"JK Cho","year":"2019","unstructured":"Cho JK, Lee W, Jang JY, et al. Validation of the oncologic effect of hepatic resection for T2 gallbladder cancer: a retrospective study. World J Surg Oncol. 2019;17(1):8.","journal-title":"World J Surg Oncol"},{"issue":"11","key":"7341_CR22","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1007\/s00268-013-2187-2","volume":"37","author":"DH Kim","year":"2013","unstructured":"Kim DH, Kim SH, Choi GH, et al. Role of cholecystectomy and lymph node dissection in patients with T2 gallbladder cancer. World J Surg. 2013;37(11):2635\u201340.","journal-title":"World J Surg"},{"issue":"12","key":"7341_CR23","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/jhbp.593","volume":"25","author":"HS Kim","year":"2018","unstructured":"Kim HS, Park JW, Kim H, et al. Optimal surgical treatment in patients with T1b gallbladder cancer: an international multicenter study. J Hepatobiliary Pancreat Sci. 2018;25(12):533\u201343.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"2","key":"7341_CR24","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3748\/wjg.v17.i2.174","volume":"17","author":"SE Lee","year":"2011","unstructured":"Lee SE, Jang JY, Lim CS, et al. Systematic review on the surgical treatment for T1 gallbladder cancer. World J Gastroenterol. 2011;17(2):174\u201380.","journal-title":"World J Gastroenterol"},{"key":"7341_CR25","doi-asserted-by":"crossref","unstructured":"de Savornin Lohman EAJ, van der Geest LG, de Bitter TJJ et al. Re-resection in incidental gallbladder cancer: Survival and the incidence of residual disease. Ann Surg. 2020;27(4):1132\u201342.","DOI":"10.1245\/s10434-019-08074-4"},{"issue":"5","key":"7341_CR26","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/s00268-009-9950-4","volume":"33","author":"K Shibata","year":"2009","unstructured":"Shibata K, Uchida H, Iwaki K, et al. Lymphatic invasion: an important prognostic factor for stages T1b-T3 gallbladder cancer and an indication for additional radical resection of incidental gallbladder cancer. World J Surg. 2009;33(5):1035\u201341.","journal-title":"World J Surg"},{"key":"7341_CR27","doi-asserted-by":"crossref","unstructured":"Yu TN, Shen B, Meng N, et al. Risk factors of lymphatic metastasis complement poor radiological detection in gallbladder cancer. World J Gastroenterol. 2014;20(1):290\u20135.","DOI":"10.3748\/wjg.v20.i1.290"},{"issue":"3","key":"7341_CR28","doi-asserted-by":"publisher","first-page":"758","DOI":"10.2214\/AJR.04.1342","volume":"186","author":"N Kalra","year":"2006","unstructured":"Kalra N, Suri S, Gupta R, et al. MDCT in the staging of gallbladder carcinoma. AJR Am J Roentgenol. 2006;186(3):758\u201362.","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"7341_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jhep.2006.03.009","volume":"45","author":"H Petrowsky","year":"2006","unstructured":"Petrowsky H, Wildbrett P, Husarik DB, et al. Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. J Hepatol. 2006;45(1):43\u201350.","journal-title":"J Hepatol"},{"issue":"1","key":"7341_CR30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jamcollsurg.2007.07.002","volume":"206","author":"CU Corvera","year":"2004","unstructured":"Corvera CU, Blumgart LH, Akhurst T, et al. 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer. J Am Coll Surg. 2004;206(1):57\u201365.","journal-title":"J Am Coll Surg"},{"issue":"6","key":"7341_CR31","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/jmri.10212","volume":"16","author":"JH Kim","year":"2002","unstructured":"Kim JH, Kim TK, Eun HW, et al. Preoperative evaluation of gallbladder carcinoma: efficacy of combined use of MR imaging, MR cholangiography, and contrast-enhanced dual-phase three-dimensional MR angiography. J Magn Reson Imaging. 2002;16(6):676\u201384.","journal-title":"J Magn Reson Imaging"},{"issue":"6","key":"7341_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198809","volume":"13","author":"S Samuel","year":"2018","unstructured":"Samuel S, Mukherjee S, Ammannagari N, et al. Clinicopathological characteristics and outcomes of rare histologic subtypes of gallbladder cancer over two decades: a population-based study. PLoS One. 2018;13(6):e0198809.","journal-title":"PLoS One"},{"issue":"3","key":"7341_CR33","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.amjsurg.2012.12.012","volume":"206","author":"R Kalayarasan","year":"2013","unstructured":"Kalayarasan R, Javed A, Sakhuja P, et al. Squamous variant of gallbladder cancer: is it different from adenocarcinoma? Am J Surg. 2013;206(3):380\u20135.","journal-title":"Am J Surg"},{"key":"7341_CR34","doi-asserted-by":"crossref","unstructured":"Widmann B, Warschkow R, Beutner U, et al. Effect of lymphadenectomy in curative gallbladder cancer treatment: a systematic review and meta-analysis. Langenbeck's Arch Surg. 2020;405(5):573\u201384.","DOI":"10.1007\/s00423-020-01878-z"},{"key":"7341_CR35","doi-asserted-by":"publisher","unstructured":"Zhu M, Cao B, Li X et al. Risk factors and a predictive nomogram for lymph node metastasis of superficial esophagogastric junction cancer. J Gastroenterol Hepatol. 2020. https:\/\/doi.org\/10.1111\/jgh.15004.","DOI":"10.1111\/jgh.15004"},{"issue":"8","key":"7341_CR36","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1016\/j.ejso.2019.03.038","volume":"45","author":"K Toge","year":"2019","unstructured":"Toge K, Sakata J, Hirose Y, et al. Lymphatic spread of T2 gallbladder carcinoma: regional lymphadenectomy is required independent of tumor location. Eur J Surg Oncol. 2019;45(8):1446\u201352.","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"7341_CR37","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/hpb.12444","volume":"17","author":"T Aloia","year":"2015","unstructured":"Aloia T, J\u0446 N, Javle M, et al. Gallbladder cancer: expert consensus statement. HPB (Oxford). 2015;17(8):681\u201390.","journal-title":"HPB (Oxford)"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07341-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-020-07341-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07341-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T23:27:35Z","timestamp":1630366055000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-07341-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,31]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["7341"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-07341-y","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,31]]},"assertion":[{"value":"28 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We received permission from the National Cancer Institute, US to access the research data file in the SEER program (reference number 10013-Nov2019). Ethics approval was waived by Ethics Committee of First Affiliated Hospital of Wenzhou Medical University, as SEER data is publicly available and without specific identifiers.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"828"}}